Ucb Biopharma Srl

This study looks at the long-term safety and effectiveness of a drug called bimekizumab for people with active axial spondyloarthritis, a type of arthritis that causes back pain and stiffness. About 500 adults who completed a previous bimekizumab study will continue taking the dr…

This study looks at the long-term safety of a daily injection called zilucoplan in children with a rare muscle-weakening disease called generalized myasthenia gravis. It includes up to 8 children who have already completed a previous study. The goal is to see if the drug is safe …

This study looks at the long-term safety and effectiveness of a drug called bimekizumab for adults with active psoriatic arthritis, a condition causing joint pain and skin patches. Over 1,100 participants who completed earlier studies will receive the drug as an injection and be …

This study looks at the long-term safety of the drug bimekizumab for people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. About 658 adults who completed earlier studies will receive open-label bimekizumab. The main goal is to track side effects …

This study tests a drug called certolizumab pegol in children aged 6 to 17 with moderate to severe plaque psoriasis. The goal is to see how the drug works in the body and if it is safe. About 49 participants will receive the drug or a placebo. This is not a cure; the drug aims to…

This study looks at the long-term safety and effectiveness of the drug zilucoplan in people with generalized myasthenia gravis, a chronic muscle weakness condition. About 200 adults who already completed a prior zilucoplan study will receive the drug for an extended period. The g…

This study tests an investigational drug called rozanolixizumab in 113 adults with MOG-AD, a rare autoimmune disease that attacks the brain and spinal cord. The goal is to see if the drug can prevent relapses (flare-ups) better than a placebo. Participants receive either the drug…

This study tests whether bimekizumab works better than risankizumab for adults with active psoriatic arthritis (PsA), a condition causing joint pain, swelling, and skin plaques. About 684 participants who have not responded well to standard treatments will receive one of the two …

This study looks at the long-term safety of a drug called dapirolizumab pegol for people with systemic lupus erythematosus (lupus). About 760 adults who completed a previous related study will receive the drug and be monitored for side effects. The goal is to see if the drug is s…

This study looks at the long-term safety of an inhaled medication called Staccato alprazolam for people aged 12 and older who have long seizures. About 300 participants will use the drug at home when a seizure starts. Researchers will track side effects and how well the drug stop…

This study looks at how the drug bimekizumab affects gene activity in people with moderate to severe plaque psoriasis, with or without psoriatic arthritis. Researchers will take small skin samples to measure changes in gene expression over 48 weeks. The goal is to better understa…